Repeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancer.

OBJECTIVES: To analyse the impact of repeating a prostate-specific antigen (PSA) level assessment on prostate biopsy decision in a cohort of men undergoing prostate biopsy. PATIENTS AND METHODS: From 2015 onwards, we consecutively enrolled, at a single institution in Italy, men undergoing 12-core tr... View More